| # | Drug | Count |
|---|---|---|
| 0 | ADALIMUMAB | 4 |
| 1 | OXALIPLATIN | 3 |
| 2 | DEXAMETHASONE | 2 |
| 3 | DEXAMETHASONE 1.5 MG | 2 |
| 4 | DIGOXIN | 2 |
| 5 | ETANERCEPT | 2 |
| 6 | GABAPENTIN | 2 |
| 7 | ACETAMINOPHEN | 1 |
| 8 | ACETAMINOPHEN 500MG | 1 |
| 9 | ACETAMINOPHEN TABLET EXTENDED RELEASE | 1 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | SILTUXIMAB | 1 | 0.0015 |
| 1 | BUPRENORPHINE HYDROCHLORIDE AND NALOXONE HYDROCHLORIDE | 1 | 0.0004 |
| 2 | ALENDRONATE SODIUM AND CHOLECALCIFEROL | 1 | 0.0004 |
| 3 | MANNITOL | 1 | 0.0002 |
| 4 | GRANISETRON HYDROCHLORIDE | 1 | 0.0001 |
| 5 | GRANISETRON | 1 | 0.0001 |
| 6 | CEFEPIME HYDROCHLORIDE | 1 | 0.0001 |
| 7 | ANAKINRA | 1 | 0.0001 |
| 8 | SORAFENIB | 1 | 0.0000 |
| 9 | OXALIPLATIN | 3 | 0.0000 |
| # | Drug class | Count |
|---|---|---|
| 0 | Kinase Inhibitor [EPC] | 3 |
| 1 | Platinum-based Drug [EPC] | 3 |
| 2 | Cardiac Glycoside [EPC] | 2 |
| 3 | Corticosteroid [EPC] | 2 |
| 4 | Tumor Necrosis Factor Blocker [EPC] | 2 |
| 5 | 5-alpha Reductase Inhibitor [EPC] | 1 |
| 6 | Alkylating Drug [EPC] | 1 |
| 7 | Benzodiazepine [EPC] | 1 |
| 8 | Central alpha-2 Adrenergic Agonist [EPC] | 1 |
| 9 | Complement Inhibitor [EPC] | 1 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Interleukin-6 Antagonist [EPC] | 1 | 0.0015 |
| 1 | Osmotic Diuretic [EPC] | 1 | 0.0002 |
| 2 | Interleukin-1 Receptor Antagonist [EPC] | 1 | 0.0001 |
| 3 | Cardiac Glycoside [EPC] | 2 | 0.0000 |
| 4 | Epidermal Growth Factor Receptor Antagonist [EPC] | 1 | 0.0000 |
| 5 | Central alpha-2 Adrenergic Agonist [EPC] | 1 | 0.0000 |
| 6 | Complement Inhibitor [EPC] | 1 | 0.0000 |
| 7 | Platinum-based Drug [EPC] | 3 | 0.0000 |
| 8 | 5-alpha Reductase Inhibitor [EPC] | 1 | 0.0000 |
| 9 | Parathyroid Hormone Analog [EPC] | 1 | 0.0000 |